Clinical trial
Role of Substance P in Post-Traumatic Stress Disorder
NCT00102102 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00102102 |
|---|---|
| Title | Role of Substance P in Post-Traumatic Stress Disorder |
| Official title | PET Evaluation of NK1 Receptor Using [18F]SPA-RQ in Post-Traumatic Stress Disorder |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Post-Traumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | [18F]SPA-RQ |
| Enrollment | 40 |
| Start date | Jan 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Jan 21, 2005 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: